Cargando…

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin

OBJECTIVES: Escherichia coli (E. coli)-induced urinary tract infection (UTI) is a common infection associated with frequent use of antibiotics and the increase in global antibiotic resistances. We aimed to determine the susceptibility profile of extended-spectrum β-lactamase (ESBL) producing E. coli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Nermin Kamal, Al Khawaja, Safaa, Al-Biltagi, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OMJ 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581151/ https://www.ncbi.nlm.nih.gov/pubmed/34804597 http://dx.doi.org/10.5001/omj.2021.95

Ejemplares similares

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Trends of central line-associated bloodstream infections in the intensive care unit in the Kingdom of Bahrain: Four years’ experience
por: Al-Khawaja, Safaa, et al.
Publicado: (2021)

Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan
por: Tseng, Sung-Pin, et al.
Publicado: (2015)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study
por: Harada, Kazuki, et al.
Publicado: (2020)

Chronic prostatitis caused by extended-spectrum β-lactamase-producing Escherichia coli managed using oral fosfomycin—A case report
por: Almeida, Francisco, et al.
Publicado: (2019)

Studies on Virulence and Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Isolates and Therapeutic Effect of Fosfomycin in Acute Pyelonephritis Mice
por: Zhang, Lingchun, et al.
Publicado: (2022)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens
por: Banerjee, Sayantan, et al.
Publicado: (2017)

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Esteve-Palau, Erika, et al.
Publicado: (2018)

Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Miyazaki, Motoyasu, et al.
Publicado: (2019)

Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples
por: Kumar, Dinesh, et al.
Publicado: (2014)

Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital
por: Kader, Abdulrahman Abdulla, et al.
Publicado: (2005)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
por: Rosso-Fernández, Clara, et al.
Publicado: (2015)

MALDI-TOF MS Approaches for the Identification of the Susceptibility of Extended-Spectrum β-Lactamases in Escherichia coli
por: Matsumura, Yuriko, et al.
Publicado: (2023)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-Producing Escherichia coli
por: Al-Agamy, Mohamed H., et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model
por: Zykov, Ilya Nikolaevich, et al.
Publicado: (2018)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Meningitis Relapse in a Neonate: From Extended-Spectrum Beta-Lactamases-Producing Escherichia coli to Escherichia coli K1
por: Alkattan, Salma S, et al.
Publicado: (2022)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
por: Li, Ya, et al.
Publicado: (2015)

Characterization of Antimicrobial Susceptibility, Extended-Spectrum β-Lactamase Genes and Phylogenetic Groups of Enteropathogenic Escherichia coli Isolated from Patients with Diarrhea
por: Jafari, Erfaneh, et al.
Publicado: (2020)

Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria
por: Mofolorunsho, Kehinde C, et al.
Publicado: (2021)

Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type
por: Branger, Catherine, et al.
Publicado: (2005)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Study of antimicrobial resistance due to extended spectrum beta-lactamase-producing Escherichia coli in healthy broilers of Jabalpur
por: Shrivastav, Arpita, et al.
Publicado: (2016)

Antimicrobial resistant and extended‐spectrum β‐lactamase producing Escherichia coli in common wild bird species in Switzerland
por: Zurfluh, Katrin, et al.
Publicado: (2019)

Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru
por: Loyola, Steev, et al.
Publicado: (2021)

Extended-Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Johnson, James R.
Publicado: (2011)

Extended Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
por: Tschudin-Sutter, Sarah, et al.
Publicado: (2010)

Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases
por: Ruiz del Castillo, Belén, et al.
Publicado: (2013)

The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China
por: Liu, Haihong, et al.
Publicado: (2015)

Extended spectrum beta lactamase producing Escherichia coli tricuspid valve endocarditis
por: Waked, Rami, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vg6dt92r7efgns12u86i3asb38